Literature DB >> 11750372

CSA/MMF/steroids versus CSA/AZA/steroids with and without basiliximab in cadaveric kidney transplantation.

U Boggi1, F Vistoli, M Del Chiaro, T V Bartolo, G Rizzo, F Mosca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11750372     DOI： 10.1016/s0041-1345(01)02361-2

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  1 in total

Review 1.  A benefit-risk assessment of basiliximab in renal transplantation.

Authors:  Ugo Boggi; Romano Danesi; Fabio Vistoli; Marco Del Chiaro; Stefano Signori; Piero Marchetti; Mario Del Tacca; Franco Mosca
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.